Fulgent Genetics Quarterly Balance Sheets Chart
Quarterly
|
Annual
Fulgent Genetics Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||||||||||||
| current assets | ||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 87,880,000 | 67,281,000 | 55,144,000 | 58,042,000 | 65,111,000 | 54,677,000 | 97,473,000 | 84,076,000 | 58,348,000 | 66,172,000 | 79,506,000 | 168,770,000 | 138,780,000 | 353,069,000 | 164,894,000 | 214,877,000 | 100,461,000 | 151,461,000 | 87,426,000 | 53,031,000 | 2,431,000 | 9,302,000 | 11,965,000 | 20,522,000 | 9,165,000 | 5,288,000 | 6,736,000 | 8,489,000 | 3,654,000 | 5,274,000 | 6,490,000 | 9,478,000 | 11,473,000 | 6,734,000 | 7,897,000 | |
| marketable securities | 205,047,000 | 253,040,000 | 202,962,000 | 155,027,000 | 246,595,000 | 251,018,000 | 326,681,000 | 383,726,000 | 400,083,000 | 438,313,000 | 446,729,000 | 402,290,000 | 376,622,000 | 232,045,000 | 285,605,000 | 255,102,000 | 283,328,000 | 258,317,000 | 211,941,000 | 21,904,000 | 18,530,000 | 18,028,000 | 16,304,000 | 11,596,000 | 17,820,000 | 24,139,000 | 24,298,000 | 24,114,000 | 26,949,000 | 23,211,000 | 19,994,000 | 16,570,000 | 17,400,000 | 20,633,000 | 12,971,000 | |
| trade accounts receivable, net of allowance for credit losses of 21,416 as of june 30, 2025, and 20,458 as of december 31, 2024 | 77,190,000 | |||||||||||||||||||||||||||||||||||
| other current assets | 58,610,000 | 24,985,000 | 26,444,000 | 56,155,000 | 30,825,000 | 28,754,000 | 32,559,000 | 32,776,000 | 35,049,000 | 32,689,000 | 48,889,000 | 21,395,000 | 26,480,000 | 19,958,000 | 22,549,000 | 32,035,000 | 34,321,000 | 32,853,000 | 40,392,000 | 30,000,000 | 6,359,000 | 3,324,000 | 2,255,000 | 1,795,000 | 2,267,000 | 2,311,000 | 2,561,000 | 2,370,000 | 2,537,000 | 2,621,000 | 2,438,000 | 2,396,000 | 1,668,000 | 1,202,000 | 906,000 | 4,883,000 |
| total current assets | 428,727,000 | 416,784,000 | 353,571,000 | 326,539,000 | 399,104,000 | 386,509,000 | 507,845,000 | 549,855,000 | 528,289,000 | 580,723,000 | 627,873,000 | 696,614,000 | 675,185,000 | 765,333,000 | 611,960,000 | 622,836,000 | 566,686,000 | 659,140,000 | 523,616,000 | 195,615,000 | 41,183,000 | 37,025,000 | 37,079,000 | 39,205,000 | 34,795,000 | 36,301,000 | 39,543,000 | 41,050,000 | 38,195,000 | 36,075,000 | 32,927,000 | 32,038,000 | 34,727,000 | 33,170,000 | 26,138,000 | 17,494,000 |
| marketable securities, long-term | 484,471,000 | 494,111,000 | 570,351,000 | 602,232,000 | 526,163,000 | 540,495,000 | 423,571,000 | 383,659,000 | 388,383,000 | 366,833,000 | 326,648,000 | 346,946,000 | 415,621,000 | 493,182,000 | 485,047,000 | 407,284,000 | 393,250,000 | 287,626,000 | 132,502,000 | 29,035,000 | 45,403,000 | 43,294,000 | 41,947,000 | 11,487,000 | 11,697,000 | 8,983,000 | ||||||||||
| intangible assets | 131,060,000 | 133,009,000 | 134,978,000 | 137,115,000 | 138,973,000 | 140,989,000 | 143,053,000 | 144,489,000 | 146,473,000 | 148,699,000 | 150,643,000 | 87,853,000 | 89,695,000 | 35,037,000 | 35,914,000 | |||||||||||||||||||||
| fixed assets | 110,223,000 | 107,077,000 | 105,549,000 | 106,810,000 | 93,368,000 | 86,723,000 | 83,464,000 | 85,265,000 | 87,556,000 | 79,083,000 | 81,353,000 | 81,807,000 | 86,049,000 | 68,622,000 | 62,287,000 | 60,166,000 | 51,086,000 | 46,987,000 | 40,199,000 | 17,385,000 | 6,013,000 | 5,698,000 | 5,974,000 | 6,396,000 | 5,937,000 | 6,046,000 | 6,446,000 | 6,853,000 | 7,325,000 | 6,853,000 | 7,272,000 | 6,490,000 | 6,737,000 | 5,894,000 | 6,234,000 | 5,178,000 |
| goodwill | 22,055,000 | 22,055,000 | 22,055,000 | 22,055,000 | 22,055,000 | 22,055,000 | 22,055,000 | 141,844,000 | 141,970,000 | 143,120,000 | 143,027,000 | 120,313,000 | 121,354,000 | 50,999,000 | 50,897,000 | 48,749,000 | 23,107,000 | |||||||||||||||||||
| other long-term assets | 23,302,000 | 32,708,000 | 33,460,000 | 39,012,000 | 32,138,000 | 32,676,000 | 34,902,000 | 38,128,000 | 49,064,000 | 45,327,000 | 44,124,000 | 61,016,000 | 61,777,000 | 34,808,000 | 10,650,000 | 8,949,000 | 8,897,000 | 5,330,000 | 3,316,000 | 975,000 | 80,000 | 160,000 | 251,000 | 409,000 | 167,000 | 231,000 | 17,000 | 18,000 | 20,000 | 30,000 | 39,000 | 71,000 | 61,000 | 69,000 | 17,000 | |
| total assets | 1,199,838,000 | 1,205,744,000 | 1,219,964,000 | 1,233,763,000 | 1,232,239,000 | 1,229,885,000 | 1,235,328,000 | 1,358,398,000 | 1,354,577,000 | 1,376,767,000 | 1,386,053,000 | 1,405,782,000 | 1,461,662,000 | 1,465,590,000 | 1,278,720,000 | 1,204,668,000 | 1,049,855,000 | 999,083,000 | 700,461,000 | 247,311,000 | 95,915,000 | 89,325,000 | 88,756,000 | 61,145,000 | 56,436,000 | 55,652,000 | 53,904,000 | 54,846,000 | 55,548,000 | 55,440,000 | 57,184,000 | 58,670,000 | 58,805,000 | 58,820,000 | 58,040,000 | 22,758,000 |
| liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||
| current liabilities | ||||||||||||||||||||||||||||||||||||
| accounts payable | 18,887,000 | 18,238,000 | 18,364,000 | 19,805,000 | 19,873,000 | 19,616,000 | 15,360,000 | 15,772,000 | 20,607,000 | 22,080,000 | 23,093,000 | 14,481,000 | 37,109,000 | 23,699,000 | 20,494,000 | 24,868,000 | 14,743,000 | 17,440,000 | 26,488,000 | 18,674,000 | 3,636,000 | 2,855,000 | 1,581,000 | 2,150,000 | 1,175,000 | 1,456,000 | 1,313,000 | 1,024,000 | 1,794,000 | 1,347,000 | 2,089,000 | 2,370,000 | 1,820,000 | 2,306,000 | 2,756,000 | 3,286,000 |
| accrued liabilities | 21,699,000 | 16,689,000 | 24,279,000 | 23,862,000 | 26,425,000 | 25,918,000 | 30,737,000 | 21,031,000 | 22,229,000 | 21,088,000 | 24,981,000 | 25,101,000 | 27,100,000 | 11,847,000 | 17,689,000 | 8,446,000 | 5,467,000 | 1,750,000 | 2,024,000 | 1,333,000 | 1,634,000 | 1,333,000 | 1,354,000 | 1,425,000 | 1,231,000 | 1,184,000 | 1,062,000 | 911,000 | 781,000 | 902,000 | 745,000 | 436,000 | 471,000 | |||
| customer deposit | 27,600,000 | 27,695,000 | 27,610,000 | 26,945,000 | 26,297,000 | 27,240,000 | 22,700,000 | 18,861,000 | 14,460,000 | 11,621,000 | 10,895,000 | 25,810,000 | 28,959,000 | 17,729,000 | 19,806,000 | 41,510,000 | 45,327,000 | 17,001,000 | ||||||||||||||||||
| contract liabilities | 2,673,000 | 2,817,000 | 2,234,000 | 2,966,000 | 2,744,000 | 2,762,000 | 2,874,000 | 2,586,000 | 2,601,000 | 2,733,000 | 3,199,000 | 2,603,000 | 10,102,000 | 14,102,000 | 14,570,000 | 7,879,000 | 6,915,000 | 13,960,000 | 26,576,000 | 18,456,000 | 622,000 | 444,000 | 365,000 | |||||||||||||
| notes payable, current | 476,000 | 476,000 | ||||||||||||||||||||||||||||||||||
| total current liabilities | 71,335,000 | 65,915,000 | 72,899,000 | 73,990,000 | 75,751,000 | 75,949,000 | 73,018,000 | 61,421,000 | 64,819,000 | 81,939,000 | 88,107,000 | 102,522,000 | 127,527,000 | 141,714,000 | 105,310,000 | 147,158,000 | 121,524,000 | 196,530,000 | 130,115,000 | 57,736,000 | 6,509,000 | 5,810,000 | 3,723,000 | 4,253,000 | 2,909,000 | 3,203,000 | 2,738,000 | 2,255,000 | 2,978,000 | 2,409,000 | 3,000,000 | 3,151,000 | 2,827,000 | 3,281,000 | 3,316,000 | 5,010,000 |
| deferred tax liabilities | 6,124,000 | 6,237,000 | 6,370,000 | 6,734,000 | 6,948,000 | 7,405,000 | 7,962,000 | |||||||||||||||||||||||||||||
| unrecognized tax benefits | 4,838,000 | 4,700,000 | 4,563,000 | 6,326,000 | 6,295,000 | 5,978,000 | 5,978,000 | 9,555,000 | 9,836,000 | 9,836,000 | 9,836,000 | 1,826,000 | 1,730,000 | 1,210,000 | 725,000 | 534,000 | 505,000 | 474,000 | 377,000 | 389,000 | ||||||||||||||||
| other long-term liabilities | 5,905,000 | 6,122,000 | 6,973,000 | 11,815,000 | 14,397,000 | 13,907,000 | 15,084,000 | 15,755,000 | 16,596,000 | 16,073,000 | 18,235,000 | 20,037,000 | 21,672,000 | 9,706,000 | 6,805,000 | 6,576,000 | 1,202,000 | 513,000 | 14,000 | 14,000 | 11,000 | 9,000 | 6,000 | 6,000 | 5,000 | 2,000 | 2,000 | |||||||||
| total liabilities | 88,202,000 | 82,974,000 | 90,805,000 | 98,865,000 | 103,391,000 | 103,239,000 | 102,042,000 | 96,564,000 | 91,251,000 | 107,848,000 | 116,178,000 | 124,385,000 | 150,929,000 | 152,630,000 | 112,840,000 | 160,215,000 | 129,130,000 | 197,517,000 | 131,074,000 | 60,356,000 | 8,872,000 | 7,953,000 | 5,979,000 | 6,619,000 | 5,294,000 | 5,691,000 | 2,752,000 | 2,266,000 | 2,987,000 | 2,415,000 | 3,006,000 | 3,399,000 | 3,072,000 | 3,524,000 | 3,561,000 | 5,513,000 |
| commitments and contingencies | ||||||||||||||||||||||||||||||||||||
| stockholders’ equity | ||||||||||||||||||||||||||||||||||||
| common stock | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 1,000 |
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding as of june 30, 2025, and december 31, 2024 | ||||||||||||||||||||||||||||||||||||
| additional paid-in capital | 550,599,000 | 543,903,000 | 543,126,000 | 532,909,000 | 522,420,000 | 511,329,000 | 501,718,000 | 514,262,000 | 506,075,000 | 495,981,000 | 486,585,000 | 477,814,000 | 504,066,000 | 507,046,000 | 501,908,000 | 483,731,000 | 482,255,000 | 450,855,000 | 418,065,000 | 201,772,000 | 148,056,000 | 146,948,000 | 146,058,000 | 117,478,000 | 115,532,000 | 114,790,000 | 114,203,000 | 113,600,000 | 113,011,000 | 112,431,000 | 111,884,000 | 111,299,000 | 110,746,000 | 110,301,000 | 109,734,000 | 73,211,000 |
| accumulated other comprehensive income | 5,998,000 | 4,335,000 | -368,000 | 9,178,000 | -877,000 | -1,102,000 | 1,205,000 | -759,000 | -212,000 | -265,000 | -216,000 | 438,000 | 607,000 | 1,049,000 | -193,000 | 146,000 | 179,000 | 203,000 | 95,000 | -82,000 | -87,000 | -44,000 | 10,000 | |||||||||||||
| retained earnings | 559,980,000 | 578,937,000 | 590,467,000 | 596,355,000 | 611,003,000 | 619,713,000 | 633,175,000 | 761,324,000 | 774,431,000 | 785,660,000 | 801,000,000 | 824,832,000 | 823,113,000 | 811,576,000 | 657,597,000 | 553,258,000 | 430,736,000 | 350,924,000 | 150,881,000 | |||||||||||||||||
| total fulgent stockholders’ equity | 1,116,580,000 | 1,127,178,000 | 1,133,228,000 | 1,138,445,000 | 1,132,549,000 | 1,129,943,000 | 1,258,698,000 | 1,259,763,000 | 1,264,448,000 | |||||||||||||||||||||||||||
| noncontrolling interest | -4,944,000 | -4,408,000 | -4,069,000 | -3,547,000 | -3,701,000 | -3,297,000 | -2,815,000 | 3,136,000 | 3,563,000 | 4,471,000 | 3,190,000 | 4,350,000 | 5,968,000 | 6,828,000 | 7,131,000 | 7,673,000 | 7,996,000 | |||||||||||||||||||
| total stockholders’ equity | 1,111,636,000 | 1,122,770,000 | 1,129,159,000 | 1,134,898,000 | 1,128,848,000 | 1,126,646,000 | 1,133,286,000 | 1,261,834,000 | 1,263,326,000 | 1,268,919,000 | 1,269,875,000 | 1,281,397,000 | 1,310,733,000 | 1,312,960,000 | 1,165,880,000 | 1,044,453,000 | 920,725,000 | 801,566,000 | 569,387,000 | 186,955,000 | 87,043,000 | 81,372,000 | 82,777,000 | 54,526,000 | 51,142,000 | 49,961,000 | 51,152,000 | 52,580,000 | 52,561,000 | 53,025,000 | 54,178,000 | 55,271,000 | 55,733,000 | 55,296,000 | ||
| total liabilities and stockholders’ equity | 1,199,838,000 | 1,205,744,000 | 1,219,964,000 | 1,233,763,000 | 1,232,239,000 | 1,229,885,000 | 1,235,328,000 | 1,358,398,000 | 1,354,577,000 | 1,376,767,000 | 1,386,053,000 | 1,405,782,000 | 1,461,662,000 | 1,465,590,000 | 1,278,720,000 | 1,204,668,000 | 1,049,855,000 | 999,083,000 | 700,461,000 | 247,311,000 | 95,915,000 | 89,325,000 | 88,756,000 | 61,145,000 | 56,436,000 | 55,652,000 | 53,904,000 | 54,846,000 | 55,548,000 | 55,440,000 | 57,184,000 | 58,670,000 | 58,805,000 | 58,820,000 | ||
| trade accounts receivable, net of allowance for credit losses of 20,935 as of march 31, 2025, and 20,458 as of december 31, 2024 | 71,478,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding as of march 31, 2025, and december 31, 2024 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 20,458 and 25,226 | 69,021,000 | |||||||||||||||||||||||||||||||||||
| redeemable preferred stock investment | 20,438,000 | 20,438,000 | 20,438,000 | 15,158,000 | 12,842,000 | 12,982,000 | 12,385,000 | 11,233,000 | 11,981,000 | 17,609,000 | 21,965,000 | 20,000,000 | ||||||||||||||||||||||||
| notes payable, current portion | 412,000 | 412,000 | 412,000 | 413,000 | 1,183,000 | 2,890,000 | 4,560,000 | 5,608,000 | 5,639,000 | 5,481,000 | 5,793,000 | 6,086,000 | ||||||||||||||||||||||||
| other current liabilities | 164,000 | 281,000 | 362,000 | 3,810,000 | 5,301,000 | 13,621,000 | 661,000 | 1,089,000 | 680,000 | 39,919,000 | 13,063,000 | 12,559,000 | 1,253,000 | |||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 25,316 as of september 30, 2024, and 25,226 as of december 31, 2023 | 57,315,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding, as of september 30, 2024, and december 31, 2023 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 25,307 as of june 30, 2024, and 25,226 as of december 31, 2023 | 56,573,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding, as of june 30, 2024, and december 31, 2023 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 25,831 and 25,226 | 52,060,000 | |||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 25,226 and 41,205 | 51,132,000 | |||||||||||||||||||||||||||||||||||
| investment margin loan | 14,999,000 | 14,999,000 | 14,999,000 | 14,999,000 | 14,999,000 | 15,137,000 | 15,107,000 | 15,077,000 | 15,048,000 | 15,019,000 | ||||||||||||||||||||||||||
| total fulgent stockholders' equity | 1,136,101,000 | 1,266,685,000 | 1,277,047,000 | 1,304,765,000 | 1,306,132,000 | 1,158,749,000 | 1,036,780,000 | 912,729,000 | ||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 29,091 and 41,205 | 49,277,000 | |||||||||||||||||||||||||||||||||||
| deferred tax liability | 9,833,000 | 243,000 | 243,000 | 243,000 | 243,000 | 503,000 | ||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -16,891,000 | -20,746,000 | -17,196,000 | -20,903,000 | -25,602,000 | -22,417,000 | -12,493,000 | -57,000 | -68,000 | -85,000 | -103,000 | |||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 33,173 and 41,205 | 34,809,000 | |||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 38,302 and 41,205 | 43,549,000 | |||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 41,205 and 11,217 | 52,749,000 | |||||||||||||||||||||||||||||||||||
| income tax payable | 426,000 | 2,804,000 | 52,163,000 | 787,000 | 17,875,000 | 26,399,000 | 120,522,000 | 53,319,000 | 14,627,000 | 56,000 | 24,000 | 60,000 | 230,000 | 124,000 | ||||||||||||||||||||||
| contingent consideration | 10,000,000 | |||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 35,410 and 11,217 | 104,159,000 | |||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 30,335 and 11,217 | 133,303,000 | |||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 22,126 and 11,217 | 160,261,000 | |||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 11,217 and 1,898 as of december 31, 2021 and 2020, respectively | 138,912,000 | |||||||||||||||||||||||||||||||||||
| notes payable | 6,147,000 | 5,947,000 | 5,899,000 | |||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at december 31, 2021 and 2020 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 6,893 and 1,898 as of september 30, 2021 and december 31, 2020, respectively | 120,822,000 | |||||||||||||||||||||||||||||||||||
| acquisition-related intangible assets | 36,684,000 | 6,829,000 | ||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 6,044 and 1,898 as of june 30, 2021 and december 31, 2020, respectively | 148,576,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at june 30, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for credit losses of 3,850 and 1,898 as of march 31, 2021 and december 31, 2020, respectively | 216,509,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 1,898 and 751, as of december 31, 2020 and 2019, respectively | 183,857,000 | |||||||||||||||||||||||||||||||||||
| equity method investments | 1,621,000 | 430,000 | 623,000 | 872,000 | 909,000 | 1,084,000 | 1,233,000 | 1,512,000 | 1,746,000 | 1,956,000 | 1,692,000 | 1,937,000 | 2,184,000 | |||||||||||||||||||||||
| operating lease right-of-use asset | 828,000 | 2,680,000 | 2,806,000 | 2,525,000 | 2,633,000 | 2,739,000 | 2,756,000 | 2,858,000 | ||||||||||||||||||||||||||||
| operating lease liabilities, short-term | 267,000 | 512,000 | 501,000 | 431,000 | 420,000 | 409,000 | 401,000 | 393,000 | ||||||||||||||||||||||||||||
| operating lease liabilities, long-term | 568,000 | 2,231,000 | 2,363,000 | 2,143,000 | 2,256,000 | 2,366,000 | 2,385,000 | 2,488,000 | ||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at december 31, 2020 and 2019 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 1,169 and 751, as of september 30, 2020 and december 31, 2019, respectively | 90,680,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at september 30, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||
| accumulated deficit | -15,426,000 | -62,064,000 | -65,385,000 | -63,429,000 | -63,133,000 | -64,595,000 | -64,926,000 | -63,018,000 | -60,965,000 | -60,370,000 | -59,321,000 | -57,664,000 | -56,040,000 | -54,947,000 | -54,922,000 | -55,154,000 | -55,967,000 | |||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 864 and 751, as of june 30, 2020 and december 31, 2019, respectively | 13,863,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at june 30, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 862 and 751, as of march 31, 2020 and december 31, 2019, respectively | 6,371,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at march 31, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 751 and 590, as of december 31, 2019 and 2018, respectively | 6,555,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at december 31, 2019 and 2018 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 611 and 590, as of september 30, 2019 and december 31, 2018, respectively | 5,292,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at september 30, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 585 and 590, as of june 30, 2019 and december 31, 2018, respectively | 5,543,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at june 30, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 588 and 590, as of march 31, 2019 and december 31, 2018, respectively | 4,563,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at march 31, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 590 and 287, as of december 31, 2018 and 2017, respectively | 5,948,000 | |||||||||||||||||||||||||||||||||||
| marketable securities, long term | 6,386,000 | 4,250,000 | 7,460,000 | 10,285,000 | 14,883,000 | 17,860,000 | 17,243,000 | 19,643,000 | 25,597,000 | |||||||||||||||||||||||||||
| deferred tax asset | 929,000 | 592,000 | 505,000 | 126,000 | 27,000 | 37,000 | 44,000 | 54,000 | 86,000 | |||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at december 31, 2018 and 2017 | ||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income loss | -35,000 | |||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 516 and 287, as of september 30, 2018 and december 31, 2017, respectively | 6,077,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at september 30, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 516 and 287, as of june 30, 2018 and december 31, 2017, respectively | 5,055,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at june 30, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 335 and 287, as of march 31, 2018 and december 31, 2017, respectively | 4,969,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at march 31, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 287 and 151, as of december 31, 2017 and 2016, respectively | 4,005,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at december 31, 2017 and 2016 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 138 and 151, respectively | 3,594,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at september 30, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 133 and 151, respectively | 4,186,000 | |||||||||||||||||||||||||||||||||||
| accumulated losses of unconsolidated companies in excess of investment | 105,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at june 30, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 151 and 151, respectively | 4,601,000 | |||||||||||||||||||||||||||||||||||
| total long-term assets | 25,650,000 | |||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at march 31, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 151 and 75, as of december 31, 2016 and 2015, respectively | 4,364,000 | |||||||||||||||||||||||||||||||||||
| current assets of discontinued operations | ||||||||||||||||||||||||||||||||||||
| non-current assets of discontinued operations | ||||||||||||||||||||||||||||||||||||
| liabilities and stockholders’/ members’ equity | ||||||||||||||||||||||||||||||||||||
| current liabilities of discontinued operations | ||||||||||||||||||||||||||||||||||||
| stockholders’/ members’ equity | ||||||||||||||||||||||||||||||||||||
| units 56,000 class d and 51,000 class p preferred units authorized, issued and outstanding, 44,000 class d and 49,000 class p common units authorized and 34,000 class d and 45,000 class p common units issued and outstanding, at december 31, 2015 | ||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at december 31, 2016 | ||||||||||||||||||||||||||||||||||||
| total stockholders’/ members’ equity | 54,479,000 | |||||||||||||||||||||||||||||||||||
| total liabilities and stockholders’/ members’ equity | 58,040,000 | 22,758,000 | ||||||||||||||||||||||||||||||||||
| cash | 8,205,000 | |||||||||||||||||||||||||||||||||||
| trade accounts receivable, net of allowance for doubtful accounts of 48 and 75, respectively | 4,406,000 | |||||||||||||||||||||||||||||||||||
| members' equity 56,000 class d and 51,000 class p preferred units authorized, issued and outstanding, 44,000 class d and 49,000 class p common units authorized and 34,000 class d and 45,000 class p common units issued and outstanding, at december 31, 2015 | ||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding at september 30, 2016 | ||||||||||||||||||||||||||||||||||||
| total stockholders’/ members’equity | 17,245,000 |
We provide you with 20 years of balance sheets for Fulgent Genetics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Fulgent Genetics. Explore the full financial landscape of Fulgent Genetics stock with our expertly curated balance sheets.
The information provided in this report about Fulgent Genetics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.